HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
47 hedge funds and large institutions have $25.5M invested in HOOKIPA Pharma in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 3 closing their positions.
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
133% more call options, than puts
Call options by funds: $107K | Put options by funds: $46K
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
15% more funds holding
Funds holding: 41 → 47 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.05% less ownership
Funds ownership: 4.45% → 4.4% (-0.05%)
13% less capital invested
Capital invested by funds: $29.4M → $25.5M (-$3.85M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$290K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$128K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$56.2K |
| 4 |
Two Sigma Investments
New York
|
+$56K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$46K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$803K |
| 2 |
BC
BIT Capital
Berlin,
Germany
|
-$185K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$66.5K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$31.8K |
| 5 |
Millennium Management
New York
|
-$11.7K |
HOOK Hedge Fund Activity: Q1 2024 in Review
47 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q1 2024, worth a combined $25.5M — down 13% from $29.4M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new HOOK positions and 3 closed out — a net gain of 6 holders — while 10 added to existing stakes and 7 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $290K. The largest seller was Morgan Stanley, cutting an estimated $803K.
- 47 institutional investors held HOOKIPA Pharma (HOOK) as of Q1 2024, up from 41 in Q4 2023.
- Funds reported $25.5M of HOOKIPA Pharma stock for Q1 2024, down 13% quarter-over-quarter.
- 9 funds opened new HOOKIPA Pharma positions in Q1 2024 and 3 closed out, a net change of +6 holders.
- The largest HOOKIPA Pharma buyer in Q1 2024 was Acadian Asset Management, an estimated $290K added.
- The largest HOOKIPA Pharma seller in Q1 2024 was Morgan Stanley, an estimated $803K sold.
Based on aggregated 13F filings for Q1 2024.